Mouse induced pluripotent stem (iPS) cell line. Expressing GFP by Nanog promoter. Order Form ( C-0033, C-00034). Please see <a href= 'http://www.cira.kyoto-u.ac.jp/e/index.html' target="_blank"> CiRA , Kyoto University </a> if you are a researcher at a for-profit organization. Yamanaka, Shinya iPS-MEF-Ng-20D-17 マウス人工多能性幹（iPS）細胞株。NanogプロモーターにてGFPを発現している。営利機関は、<a href='http://www.cira.kyoto-u.ac.jp/j/research/material_about.html' target="_blank"> 京都大学iPS細胞研究所</a>から配布。 <a href="http://www.cira.kyoto-u.ac.jp/" target="_blank">http://www.cira.kyoto-u.ac.jp/</a> マウス人工多能性幹（iPS）細胞株。NanogプロモーターにてGFPを発現している。営利機関は、<a href='https://www.cira-foundation.or.jp/j/index.html' target="_blank"> 公益財団法人京都大学iPS細胞研究財団</a>から配布。 1) The RECIPIENT belongs to a not-for-profit academic organization (i.e., a university or another institution of higher education or any nonprofit scientific or educational organization, including government agencies). 2) The RECIPIENT should read <a href='http://en.brc.riken.jp/news/gfp_conclude.shtml' target="_blank"> the GFP Transfer License contracted between the RIKEN BRC and GE Healthcare Bio-Sciences.</a> 3) Attach <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/APS0001en.pdf' target="_blank">TERMS and CONDITIONS</a> to MTA (C-0034) . 1) 利用者は学術機関に所属している者に限る。2) <a href='http://ja.brc.riken.jp/news/gfp_conclude.shtml' target="_blank">GE Healthcare Bio-Sciences社とBRCとのGFP Transfer License 締結</a> を確認の上、手続きを取ること。 3) <a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/APS0001.pdf' target="_blank">別紙1</a>を提供同意書 (C-0028) に添付すること。 Mouse induced pluripotent stem (iPS) cell line. Expressing GFP by Nanog promoter.Please see <a href= "https://www.cira-foundation.or.jp/e/" target="_blank" rel="noreferrer">CiRA Foundation</a>, if you are a researcher at a for-profit organization. APS0001